FINWIRES · TerminalLIVE
FINWIRES

Manulife Financial's Canada Business May Rebound Earlier, Stronger Than Expected, RBC Says

By

Manulife Financial's (MFC) Canada business may rebound earlier and more strongly than expected but sustained outperformance would require stronger contributions from Asia and Global Wealth and Asset Management, RBC Capital Markets said Friday.

The company's Q1 core EPS was CA$1.06 ($0.77), below RBC's estimate of CA$1.11 and consensus of CA$1.10. The miss was driven by weaker-than-expected results in Canada, Corporate & Other, and Global Wealth and Asset Management, according to the note.

RBC lowered its core EPS estimates to CA$4.44 from CA$4.57 in 2026 and to CA$4.90 from CA$4.97 in 2027.

Canada core earnings of CA$352 million were below RBC's estimate of CA$409 million. The firm expects Canada insurance experience to normalize by year-end but models Canada core earnings to decline about 6% in 2026.

Corporate & Other posted a core loss of CA$115 million, larger than RBC's expected loss of CA$65 million, while GWAM core earnings of CA$448 million also came in below forecast.

RBC kept an outperform rating on Manulife Financial with a price target of CA$55.

Price: $37.52, Change: $-0.02, Percent Change: -0.05%

Related Articles

Wire

Aardvark Therapeutics' Investigational New Drug Application for ARD-101 Put on Clinical Hold by FDA

Aardvark Therapeutics (AARD) said late Thursday the US Food and Drug Administration placed a full clinical hold on its investigational new drug application for ARD-101 to treat hyperphagia associated with Prader-Willi Syndrome.The hold applies to all ongoing clinical studies under the IND, the company said, adding that it is in discussions with the FDA for resolution of the clinical hold and to fix a path forward for the drug candidate.The company also plans to unblind clinical data from the HERO and OLE trials to assess the totality of efficacy and safety data, according to the company.The company said it had $91.2 million in cash and cash equivalents as of March 31, adequate to fund operations into mid-2027.

$AARD
Wire

Sky Harbour Q1 Loss Narrows, Revenue Rises; Shares Fall After Hours

Sky Harbour Group (SKYH) reported a Q1 loss late Thursday of $0.16 per diluted share, narrowing from a loss of $0.19 a year earlier.Analysts polled by FactSet expected a loss of $0.13.Revenue in the three months ended March 31 rose to $8.73 million from $5.59 million a year earlier.Analysts surveyed by FactSet expected $9.8 million.Sky Harbour shares fell 4.9% in after-hours trading.

$SKYH
Wire

KinderCare Learning Q1 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours

KinderCare Learning (KLC) reported Q1 adjusted earnings late Thursday of $0.04 per diluted share, down from $0.23 a year earlier.Analysts surveyed by FactSet expected a loss of $0.01.Revenue in the three months ended April 4 rose to $672.5 million from $668.2 million a year earlier.Analysts surveyed by FactSet expected $669.1 million.The company boosted full-year adjusted EPS guidance to $0.15 to $0.25 from the previous forecast of $0.10 to $0.20. It affirmed the revenue outlook of $2.7 billion to $2.75 billion.Analysts expect EPS of $0.15 on revenue of $2.71 billion.KinderCare shares fell 6.2% in after-hours trading.

$KLC